Decreased expression of TXNIP is associated with poor prognosis and immune infiltration in kidney renal clear cell carcinoma
Open Access
- 12 January 2024
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 27 (3) , 1-16
Abstract
The most prevalent and insidious type of kidney cancer is kidney clear cell carcinoma (KIRC). Thioredoxin‑interacting protein (TXNIP) encodes a thioredoxin‑binding protein involved in cellular energy metabolism, redox homeostasis, apoptosis induction and inflammatory responses. However, the relationship between TXNIP, immune infiltration and its prognostic value in KIRC remains unclear. Thus, the present study evaluated the potential for TXNIP as a prognostic marker in patients with KIRC. Data from The Cancer Genome Atlas were used to assess relative mRNA expression levels of TXNIP in different types of cancer. The protein expression levels of TXNIP were evaluated using the Human Protein Atlas. Enrichment analysis of genes co‑expressed with TXNIP was performed to assess relevant biological processes that TXNIP may be involved in. CIBERSORT was used to predict the infiltration of 21 tumor‑infiltrating immune cells (TIICs). Univariate and multivariate Cox regression analyses were used to assess the relationship between TXNIP expression and prognosis. Single‑cell RNA‑sequencing datasets were used to evaluate the mRNA expression levels of TXNIP in certain immune cells in KIRC. The CellMiner database was used to analyze the relationship between TXNIP mRNA expression and drug sensitivity in KIRC. The results from the present study demonstrated that TXNIP expression was significantly decreased in KIRC tissue compared with that in normal tissue, as confirmed by western blotting and reverse transcription‑quantitative PCR. In addition, downregulated TXNIP expression was significantly associated with poor prognosis, a high histological grade and an advanced stage. The Cell Counting Kit‑8 assay demonstrated that TXNIP overexpression significantly suppressed tumor cell proliferation. Univariate and multivariate Cox regression analyses indicated that TXNIP served as a separate prognostic factor in KIRC. Moreover, TXNIP expression was significantly correlated with the accumulation of several TIICs and its overexpression significantly downregulated the mRNA expression levels of CD25 and cytotoxic T‑lymphocyte‑associated protein 4, immune cell surface markers in CD4+ T lymphocytes. In conclusion, TXNIP may be used as a possible biomarker to assess unfavorable prognostic outcomes and identify immunotherapy targets in KIRC.Keywords
This publication has 55 references indexed in Scilit:
- Repurposing Vorinostat for the Treatment of Disorders Affecting BrainNeuroMolecular Medicine, 2021
- Histone deacetylase 10 exerts anti‐tumor effects on cervical cancer via a novel microRNA‐223/TXNIP/Wnt/β‐catenin pathwayIUBMB Life, 2021
- The Cancer Genome Atlas: Creating Lasting Value beyond Its DataCell, 2018
- Profiling Tumor Infiltrating Immune Cells with CIBERSORT2018
- CXCL9: evidence and contradictions for its role in tumor progressionCancer Medicine, 2016
- Systemic therapy in metastatic renal cell carcinomaWorld Journal of Urology, 2016
- Oncogenic activation of the PI3K/Akt pathway promotes cellular glucose uptake by downregulating the expression of thioredoxin-interacting proteinCellular Signalling, 2016
- Sequencing of Agents for Metastatic Renal Cell Carcinoma: Can We Customize Therapy?European Urology, 2012
- Prognostic Impact of the 2009 UICC/AJCC TNM Staging System for Renal Cell Carcinoma with Venous ExtensionEuropean Urology, 2011
- Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyvitamin D-3Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1994